The role of basal ganglia in the control of generalized absence seizures

Epilepsy Research

Volumn 32, Issue 1-2, 1998, Pages 213-223

  Deransart, C ^a   Vercueil, L ^a   Marescaux, C ^a   Depaulis, A ^a  

^a INSERM   (France)

Author keywords

Absences; Basal ganglia; Dopamine; Epilepsy; GABA; Globus pallidus; Glutamate; Nucleus accumbens; Rat; Seizures; Striatum; Substantia nigra; Subthalamic nucleus; Superior colliculus; Ventral pallidum

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID;

ABSENCE; ANIMAL MODEL; BASAL GANGLION; CONFERENCE PAPER; CORPUS STRIATUM; GABAERGIC SYSTEM; GLOBUS PALLIDUS; HUMAN; NEUROMODULATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUPERIOR COLLICULUS;

ANIMALS; BASAL GANGLIA; BRAIN; EPILEPSY, ABSENCE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MODELS, NEUROLOGICAL; NEURONS; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0032168787     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00053-9     Document Type: Conference Paper

References (84)

1. Afifi A. Basal ganglia: functional anatomy and physiology. Part 2. J. Child Neurol. 9:1994;352-361.
2. Akkal D., Burbaud P., Audin J., Bioulac B. Responses of substantia nigra pars reticulata neurons to intrastriatal D1 and D2 dopaminergic agonist injections in the rat. Neurosci Lett. 213:1996;66-70.
3. Alexander G., Crutcher M. Functional architecture of basal ganglia circuits neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
4. Al-Tajir G., Starr M.S. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience. 43:1991;51-57.
5. Al-Tajir G., Starr M.S. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharm. Biochem. Behav. 39:1991;109-113.
6. Beckstead R., Domesick V., Nauta W. Efferents connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175:1979;191-217.
7. Benazzouz A., Piallat B., Pollak P., Benabid A.L. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci. Lett. 189:1995;77-80.
8. Besson M., Graybiel A., Quinn B. Co-expression of neuropeptides in the cat's striatum: an immunohistological study of substance P, dynorphin B and enkephalin. Neuroscience. 39:1990;33-58.
9. Bevan M.D., Smith A.D., Bolam J.P. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience. 75:1996;5-12.
10. Calabresi P., DeMurtas M., Bernardi G. The neostriatum beyond the motor function: experimental and clinical evidence. Neuroscience. 78:1997;39-60.
11. Cavalheiro E., Turski L. Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats. Brain Res. 377:1986;173-176.
12. Chevalier G., Deniau J. Disinhibition as a basic procss in the expression of striatal functions. Trends Neurosci. 13:1990;277-280.
13. Chevalier G., Vacher S., Deniau J., Desban M. Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res. 334:1985;215-226.
14. Crutcher M., DeLong M. Single cell studies in the primate putamen II. Relations to direction of movements and patterns of muscular activity. Exp. Brain Res. 53:1984;244-258.
15. Csernansky J., Melletin J., Beauclair L., Lombrozo L. Mesolimbic dopaminergicsupersensivity following electrical kindling of the amygdala. Biol. Psychiatry. 23:1988;285-294.
16. Danober L., Deransart C., Depaulis A., Vergnes M., Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog. Neurobiol. 55:1998;27-57.
17. De Sarro G., Meldrum B., Reavill C. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur. J. Pharmacol. 106:1985;175-179.
18. Delong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
19. Depaulis A., Vergnes M., Marescaux C., Lannes B., Warter J. Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat. Brain Res. 448:1988;20-29.
20. Depaulis A., Snead O.I., Marescaux C., Vergnes M. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res. 498:1989;64-72.
21. Depaulis A., Liu Z., Vergnes M., Marescaux C., Micheletti G., Warter J. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res. 5:1990;192-198.
22. Depaulis A., Vergnes M., Marescaux C. Endogenous control of epilepsy: the nigral inhibitory system. Prog. Neurobiol. 42:1994;33-52.
23. Deransart C., Marescaux C., Depaulis A. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat. Neuroscience. 71:1996;721-728.
24. Drinkenburg W.H.I.M., Coenen A.M.L., Vossen J.M.H., Vanluijtelaar E.L.J.M. Sleep deprivation and spike-wave discharges in epileptic rats. Sleep. 18:1995;252-256.
25. Dybdal, D., Gale, K., 1996. Anticonvulsant effects of focal inhibition of the subthalamic nucleus, Ann. Meeting Soc. Neurosci. Vol. 22-2, Washington, November.
26. Fallon J.H., Loughlin S.E. Substantia nigra. Paxinos G. The Rat Nervous System. second:1995;215-238 Academic Press, New York.
27. Féger J., Robledo P. The effects of activation or inhibition of the subthalamic nucleus on the metabolic and electrophysiological activities within the pallidal complex and the substantia nigra in the rat. Eur. J. Neurosci. 3:1992;947-952.
28. Filloux F., Dawson T., Wamsley J. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase. Brain Res. Bull. 20:1988;447-459.
29. Fiorino D.F., Coury A., Phillips A.G. Dynamic changes in nucleus accumbens dopamine efflux during the Coolidge effect in male rats. J. Neurosci. 17:1997;4849-4855.
30. Gale K. Mechanisms of seizure control mediated by gamma aminobutyric acid: role of the substantia nigra. Fed. Proc. 44:1985;2414-2424.
31. Gale K., Pazos A., Maggio R., Japikse K., Pritchard P. Blockade of GABA receptors in superior colliculus protects against focally evoked limbic motor seizures. Brain Res. 603:1993;279-283.
32. Garant D.S., Gale K. Substantia nigra-mediated anticonvulsivant actions: role of nigral output pathways. Exp. Neurol. 97:1987;143-159.
33. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
34. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
35. Groenewegen H., Berendse H. Anatomical relationships between the prefrontal cortex and the basal ganglia in the rat. Thierry A.E.A. Motor and Cognitive Functions of the Prefrontal Cortex. 1994;51-77 Springer, Berlin.
36. Guey J., Bureau M., Dravet C., Roger J. A study of the rhythm of petit mal absences in children in relation to prevailing situations. The use of EEG telemetry during psychological examinations, school exercises and periods of inactivity. Epilepsia. 10:1969;441-451.
37. Guyenet P., Aghajanian G. Antidromic identification of dopaminergic and other output neurons of he rat substantia nigra. Brain Res. 150:1993;69-84.
38. Heimer L., Zahm D., Alheid G. Basal ganglia. Paxinos G. The Rat Nervous System. 1995;579-628 Academic Press, New York.
39. Hsu K.S., Huang C.C., Yang C.H., Gean P.W. Presynaptic D-2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res. 690:1995;264-268.
40. Huang K.X., Walters J.R. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. Neuroscience. 75:1996;757-775.
41. Huang Q., Zhou D., Chase K., Gusella J., Aronin N., DiFiglia M. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system and thalamic reticular nucleus. Proc. Natl. Acad. Sci. USA. 89:1992;11988-11992.
42. Huff R.M. Signal transduction pathways modulated by the D-2 subfamily of dopamine receptors. Cell Signal. 8:1996;453-459.
43. Jensen A.A., Pedersen U.B., Din N., Andersen P.H. The dopamine D-1 receptor family: structural and functional aspects. Biochem. Soc. Trans. 24:1996;163-169.
44. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 68:1994;363-379.
45. Joyce J., Marshall J. Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: localization to intrinsic neurons and not to neocortical afferents. Neuroscience. 20:1987;773-795.
46. Jung R. Blocking of petit-mal attacks by sensory arousal and inhibition of attacks by an active change in attention during the epileptic aura. Epilepsia. 3:1962;435-437.
47. Koob G., Bloom F. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
48. Lannes B., Micheletti G., Vergnes M., Marescaux C., Depaulis A., Warter J. Relationship between spike-wave discharges and vigilance levels in rats with spontaneous petit mal-like epilepsy. Neurosci. Lett. 94:1988;187-191.
49. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
50. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
51. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. USA. 87:1990;230-234.
52. Lester J., Fink S., Aronin N., DiFiglia M. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res. 621:1993;106-110.
53. Levy R., Hazrati L.-N., Vila M., Hassani O.-K., Mouroux M., Ruberg M., Asensi H., Agid Y., Féger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
54. Löscher W., Schmidt D. Which animal model should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
55. Maggio R., Gale K. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra. Exp. Neurol. 105:1989;184-188.
56. Marescaux C., Vergnes M., Depaulis A. Genetic absence epilepsy in rats from strasbourg - a review. J. Neural Transm. Suppl. 35:1992;37-70.
57. Maurice N., Deniau J.M., Menetrey A., Glowinski J., Thierry A.M. Position of the ventral pallidum in the rat prefrontal cortex basal ganglia circuit. Neuroscience. 80:1997;523-534.
58. Meldrum B., Millan M., Patel S., De Sarro G. Anti-epileptic effects of focal micro-injection of excitatory amino acid antagonist. J. Neural Transm. 72:1988;191-200.
59. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50:1996;381-425.
60. Mogenson G., Jones D., Yim C. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14:1980;69-97.
61. Morari M., Oconnor W.T., Ungerstedt U., Bianchi C., Fuxe K. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat. 2. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral gabaergic transmission and motor function. Neuroscience. 72:1996;89-97.
62. Nakanishi H., Kita H., Kitai S. Intracellular study of substantia nigra pars reticulata neurons in an in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic nucleus stimulation. Brain Res. 437:1987;45-55.
63. Niedermeyer E. Primary (idiopathic) generalized epilepsy and underlying mechanisms. Clin. Electroencephal. 27:1996;1-21.
64. Phillipson O., Griffiths A. The topographic order of inputs to nucleus accumbens in the rat. Neuroscience. 16:1985;275-296.
65. Redgrave P., Dean P., Simkins M. Intratectal glutamate suppresses pentylenetetrazole-induced spike-and-wave discharges. Eur. J. Pharmacol. 158:1988;283-287.
66. Robertson G.S., Jian M. D-1 and D-2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64:1995;1019-1034.
67. Robledo P., Féger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518:1990;47-54.
68. Salamone J. The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of dynamic activity of nucleus accumbens dopamine. J. Neurosci. Methods. 64:1996;137-149.
69. Sommer W., Rimondini R., Oconnor W., Hansson A.C., Ungerstedt U., Fuxe K. Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat. Proc. Natl. Acad. Sci. USA. 93:1996;14134-14139.
70. Starr M.S. Glutamate/dopamine D-1/D-2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse. 19:1995;264-293.
71. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
72. Surmeier D.J., Eberwine J., Wilson C.J., Cao Y., Stefani A., Kitai S.T. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. Natl. Acad. Sci. USA. 89:1992;178-10182.
73. Turski L., Cavalheiro E., Turski W., Meldrum B. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effect of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience. 18:1986;61-77.
74. Turski L., Meldrum B.S., Cavalheiro E.A., Calderazzo-Filho L.S., Bortolotto Z.A., Ikonomidou-Turski C., Turski W.A. Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc. Natl. Acad. Sci. USA. 84:1987;1689-1693.
75. Turski L., Cavalheiro E.A., Bortolotto Z.A., Ikonomidou-Turski C., Kleinrok Z., Turski W.A. Dopamine-sensitive anticonvulsant site in the rat striatum. J. Neurosci. 8:1988;3837-3847.
76. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 3:1989;154-171.
77. Veliskova J., Velsek L., Moshe S.L. Subthalamic nucleus: a new anticonvulsant site in the brain. Neuroreport. 7:1996;1786-1788.
78. Vergnes M., Marescaux C., Boehrer A., Depaulis A. Are rats with genetic absence epilepsy behaviorally impaired? Epilepsy Res. 9:1991;97-104.
79. Wahnschaffe U., Löscher W. Anticonvulsant effects of ipsilateral but not controlateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats. Brain Res. 553:1991;181-187.
80. Warter J., Vergnes M., Depaulis A., Tranchant C., Rumbach L., Micheletti G., Marescaux C. Effect of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology. 27:1988;269-274.
81. Wilson C., Nomikos G., Collu M., Fibiger H. Dopaminergic correlates of motivated behavior: importance of drive. J. Neurosci. 15:1995;5169-5178.
82. Wurpel J., Sperber E., Moshé S. Age-dependent differences in the anticonvulsant effects of 2-amino-7-phosphono-heptanoic acid or ketamine infusions into the substantia nigra of rats. Epilepsia. 33:1992;439-443.
83. Xie X.-H., Tietz E.I., Rosenberg H.C. Anti-pentylenetetrazol effect of intranigral 2-amino-7-phosphonoheptanoate attenuated by muscimol. Brain Res. 544:1991;331-334.
84. Yang C.R., Mogenson G.J. Ventral pallidal neurons responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res. 489:1989;237-246.